You are here Home Resources and guidance Sponsors Novartis Pharmaceuticals Pty Ltd Australia Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian public assessment report (AusPar) (1) Date 2018 (1) Search Sponsor content1 result(s) found, displaying 1 to 1 AusPAR: Ofatumumab 25 January 2018 Australian public assessment report (AusPar) Australian Public Assessment Report for Ofatumumab
AusPAR: Ofatumumab 25 January 2018 Australian public assessment report (AusPar) Australian Public Assessment Report for Ofatumumab